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The leaves of Ilex kudingcha are used as an ethnomedicine in the treatment of symptoms related with diabetes mellitus and
obesity throughout the centuries in China. The present study investigated the antidiabetic activities of an active components
group (ACG) obtained from Ilex kudingcha in alloxan-induced type 2 diabetic mice. ACG signiﬁcantly reduced the elevated levels
of serum glycaemic and lipids in type 2 diabetic mice. 3-Hydroxy-3-methylglutaryl coenzyme A reductase and glucokinase were
upregulated signiﬁcantly, while fatty acid synthetase, glucose-6-phosphatase catalytic enzyme was downregulated in diabetic mice
aftertreatmentofACG.TheseﬁndingsclearlyprovidedevidencesregardingtheantidiabeticpotentialsofACGfromIlexkudingcha.
Using LC-DAD/HR-ESI-TOF-MS, six major components were identiﬁed in ACG. They are three dicaﬀeoylquinic acids that have
been reported previously, and three new triterpenoid saponins, which were the ﬁrst time to be identiﬁed in Ilex kudingcha.I ti s
reasonable to assume that antidiabetic activity of Ilex kudingcha against hyperglycemia resulted from these six major components.
Also, synergistic eﬀects among their compounds may exist in the antidiabetic activity of Ilex kudingcha.
1.Introduction
Diabetes mellitus is one of the most common chronic
and systemic diseases in the world. The World Health
Organization estimated that diabetes is responsible for
approximately 5% of all deaths worldwide and predicted
a >50% increase in diabetes-related mortality in 10 years
[1]. Dietary restrictions, exercise, and administration of oral
glucose-lowering agents are applied widely to control blood
g l u c o s ec o n c e n t r a t i o n sa st i g h t l ya sp o s s i b l e[ 2]. Moreover,
herbal supplements and other alternative medicines have
gradually increased to be used for treatment of diabetic
disorders. Kudingcha is the leaves of Ilex kudingcha C.
J. Tseng (Aquifoliaceae), and a folk medicine for therapy
of diabetes in China. Also, the Ilex kudingcha have been
report to possess antioxidative, hypotensive, antiobesity and
antidiabetic activities and contain saponin, polyphenol, and
ﬂavones [3–6]. However, there is a lack of reliable data
about bioactive components (ACG of Ilex kudingcha)f o ri t s
antiobesity and antidiabetic activities and the eﬀect of ACG
on diabetes and obesity.
The present study focused on the eﬀectiveness of ACG
on type 2 diabetic mice induced by alloxan. The physiologic
and biochemical changes that resulted from ACG treatment
were examined. Also, the expression levels of the genes
related to glycemia and lipids metabolism were investigated
to elucidate the antidiabetic potentials of ACG on type 2
diabetes.Furthermore,aseriesofLC-DAD/HR-ESI-TOF-MS
analyses were carried out to identify the structures of the
components present in ACG.
2.MaterialsandMethods
2.1. Drugs and Chemicals. The leaves of Ilex kudingcha,
which grown in Hainan area of China, was obtained from
Xianning Kang Jin Chinese Herbal Pieces Co., Ltd. (Hubei,
China). The leaves of Ilex kudingcha were identiﬁed and
authenticated by the taxonomist of Key Laboratory of Chi-
neseMedicineResourceandCompoundPrescription(Hubei
University of Chinese Medicine), Ministry of Education. A
voucher specimen (No. 020) was deposited in herbarium of
the Key Laboratory.2 Evidence-Based Complementary and Alternative Medicine
Table 1: Polymerase chain reaction primer sequences.
Mouse
gene Primer Sequence∗∗
β-Actin Forward
Reverse
CAC TgT gCC CAT CTA CgA
CAg gAT TCC ATA CCC AAg
Fasn∗ Forward
Reverse
Aag Cgg CCA TTT CCA TTg
CgT ACC Tgg ACA Agg ACT TTg
G6pc∗ Forward
Reverse
AAT CTC CTC Tgg gTg gCA
gCT gTA gTA gTC ggT gTC C
Hmgcr∗ Forward
Reverse
gTT CTT TCC gTg CTg TgT TCT ggA
CTg ATA TCT TTA gTg CAg AgT gTg gCAC
Gck∗ Forward
Reverse
CCC TgT Aag gCA CgA AgA
Cgg Aga AgT CCC Acg Atg T
∗Fasn: fatty acid synthetase; G6pc: glucose-6-phosphatase catalytic enzyme;
Hmgcr: 3-hydroxy-3-methylglutaryl coenzyme A reductase; Gck: glucoki-
nase.
∗∗Primers are shown 5  −→ 3 .
Alloxan was purchased from Sigma Ltd. (USA). Phen-
formin was obtained from Merck Sharp pharmaceutical Ltd.
(Beijing, China). Cholesterol, triglyceride, blood glucose,
superoxide dismutase, malondialdehyde, and nonesteriﬁed
fatty acid assay kits were purchased from Shanghai Mind
Bioengineering Co. Ltd. (Shanghai, China).
2.2. Fractionation of the Extract from Ilex Kudingcha. Four
kilograms of Ilex kudingcha were boiled in 40L distilled
water for 3h, and this extraction process was repeated for
3 times. The four extracts were combined and concentrated
on a rotary evaporator under reduced pressure followed
by drying in a freeze dryer. The lyophilized powder of
water extract from Ilex kudingcha was extracted with 20-fold
(w/v) 100% MeOH at 65◦C for 3h and the extraction was
repeatedfor3times.Thecombined100%MeOHextractwas
evaporated and dried by a freeze dryer to yield fraction A.
The residue was then extracted with 50% MeOH/H2O, using
same extraction process, to get fraction B. The residue was
used as fraction C. The fractions A, B, and C represented
25.4%, 8.4%, and 1.2%, respectively, of the material of Ilex
kudingcha (w/w). The fractions A, B, and C were stored at
−80◦C.
2.3. Animal Experimental Design. In a previous study, we
had compared the antidiabetic eﬀect of the fractions A,
B, and C and water extract of Ilex kudingcha. The results
showed that fractions A and B possess a potent antidiabetic
activity on mice with type 2 diabetes induced by alloxan.
However, the last residue (fraction C) had no activity under
these experimental conditions. In addition, the conclusion
from our previous LC-MS data was that the same chemical
compositions were present in both fractions A and B, but
with diﬀerent ratios between components in fractions A and
B (data not shown). This study focused on the antidiabetic
eﬀect of fraction A (ACG).
Male mice (25–30g) were purchased from Wuhan Insti-
tute of Biological Products (Wuhan, China). The mice were
housed 8 per cage in a 12h light/dark cycle at 18–23◦C
with a humidity of 55–60% for at least 1 week before each
study. All animal experimental procedures were approved by
the Institutional Animal Care and Use Committee of Hubei
University of Chinese Medicine.
Based on the previously established method [7–9], type
2 diabetes was induced by a high-fat diet and alloxan. A
high-fat diet contained basic diet (78.8%), egg yolk (10%),
lard oil (10%), cholesterol (1%), and cholate (0.2%). The
mice were fed this diet for one month, then combined
with a twice low-dose fresh alloxan (60mg·Kg−1× 2). 48h
after the last alloxan administration, fasting blood was
collected from caudal vein of all the animals to determine
the glucose concentration. A mouse that had a blood glucose
concentrationhigherthan11mmol·L−1 wasregardedastype
2 diabetes.
All animals were randomly allocated to one of 6 diﬀerent
4-week treatments, with 8 mice per group: C:c o n t r o l
group with 0.4mL·d−1 of distilled water; T: Type 2 diabetic
model group with 0.4mL·d−1 of distilled water; P:T y p e2
diabetic positive group with 50mg·Kg−1·d−1 phenformine;
KL: Type 2 diabetic low-dose-treated group with 1.27g
ACG·Kg−1·d−1; KM: Type 2 diabetic medium-dose-treated
group with 2.54g ACG·Kg−1·d−1; KH: Type 2 diabetic high-
dose-treated group with 3.81g ACG·Kg−1·d−1. The 1.27g,
2.54g and 3.81g ACG were equivalent to 5g, 10g, and 15g
Ilex kudingcha. The samples (phenformine or ACG powder)
were dissolved in 0.4mL distilled water for intragastric
administration. Food and water intake were checked every
4d a y s .
2.4. Collection of Blood and Organ Sample. Blood samples
were collected from caudal vein of all the animals every 7
days. After 4 weeks of treatment, all animals were deprived
of food for 10h and given a 2g·Kg−1 glucose solution by
intragastric administration. Tail blood was collected before
the administration of the glucose and 0.5, 1 and 2h later
for oral glucose tolerance test (OGTT). The whole blood
was collected by ophthalmectomy after OGTT. The serum
was separated by centrifugation at 3500rpm for 15min and
stored at −80◦C until the analysis was carried out. The
serum samples were analyzed for cholesterol, triglyceride,
blood glucose, superoxide dismutase, malondialdehyde, and
nonesteriﬁedfattyacid.Inaddition,liversegmentsandother
organs from each animal were quickly removed and stored at
−80◦C. The collected liver samples were prepared for total
RNA extraction.
2.5. Biochemical Analysis. The levels of blood glucose were
measured with a commercial kit by a glucose oxidase
method. Serum triglyceride and cholesterol concentrations
were determined with assay kits by a glycerol-3-phosphate
oxidase method and a cholesterol oxidase method, respec-
tively. The levels of serum superoxide dismutase, malondi-
aldehyde, and non-esteriﬁed fatty acid were determined by
commercial kits according to manufacturer’s protocols.
2.6. Quantitative Real-Time RT-PCR. Total RNA from
mouse liver was extracted using Simply P Total RNAEvidence-Based Complementary and Alternative Medicine 3
Table 2: Physiological and Biochemical parameters of mice in various groups after 4-week treatment of ACG (mean ± SD, n = 8).
CT P K L KM KH
BW∗∗ (g) 30.96 ± 1.45∗ 38.53 ± 1.87 36.45 ± 3.56 35.47 ± 3.68 34.29 ± 3.81 32.58 ± 2.04∗
GLU∗∗ (mmol/L) 5.28 ± 0.90∗ 13.56 ± 1.02 8.60 ± 1.01∗ 10.50 ± 1.10∗ 9.80 ± 1.21∗ 8.81 ± 1.02∗
TC∗∗ (mmol/L) 2.30 ± 0.32∗ 7.90 ± 0.44 6.54 ± 0.34∗ 6.67 ± 0.43∗ 6.03 ± 0.37∗ 4.90 ± 0.22∗
TG∗∗ (mmol/L) 1.03 ± 0.42 1.38 ± 0.47 1.28 ± 0.31 1.34 ± 0.33 1.29 ± 0.58 0.98 ± 0.13∗
SOD∗∗ (U/mL) 248.45 ± 49.56∗ 135.90 ± 46.72 227.67 ± 52.40 205.34 ± 43.50 224.91 ± 64.30 256.46 ±
56.47∗
MDA∗∗
(nmol/mL) 6.24 ± 1.30∗ 16.74 ± 3.65 12.08 ± 6.09 14.45 ± 3.21 14.31 ± 4.65 13.24 ± 3.81
NEFA∗∗ (mmol/L) 1.89 ± 0.19∗ 3.75 ± 0.44 2.43 ± 0.15∗ 3.04 ± 0.24 2.97 ± 0.47 2.19 ± 0.21∗
∗P<0.05 signiﬁcantly diﬀerent from T group.
∗∗BW: body weight; TC: cholesterol; TG: triglyceride; GLU: serum glucose; SOD: superoxide dismutase; MDA: malondialdehyde; NEFA: nonesteriﬁed fatty
acid.
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Figure 1: Food (a) and water (b) intake during treatment with ACG in type 2 diabetic mice. ∗P<0.05 versus T group.
Table 3: HR-ESI-TOF-MSn data of major phenolic compounds identiﬁed in ACG.
CID spectra of [M-H]− (relative intensity, %) CID spectra of [M+H]+
Peak no.∗ Rt min [M-H]− pathway 1 pathway 2 (relative intensity, %)
B
∗∗
1 B
∗∗
2 A
∗∗
2 A
∗∗
1 [M+H]+ B
∗∗
3 Lit. report
chlorogenic acids isomers
1 10.4 353 (0.1) 179 (7.0) 135 (100) 191 (48.2) 355 (0.1) 163 (100) [10, 11]
2 13.2 353 (0.3) 179 (1.8) 135 (6.7) 173 (2.9) 191 (100) 355 (0.1) 163 (100) [10, 11]
3 13.8 353 (0.4) 179 (6.0) 135 (100) 173 (11.1) 191 (41.1) 355 (0.1) 163 (100) [10, 11]
dicaﬀeoylquinic acids isomers
8 24.2 515 (0.1) 179 (100) 135 (92.9) 173 (87.2) 191 (70.4) 517 (0.1) 163 (100) [10, 11]
9 25.9 515 (0.1) 179 (48.8) 135 (43.5) 173 (4.3) 191 (100) 517 (0.1) 163 (100) [10, 11]
10 27.0 515 (0.1) 179 (86.9) 135 (58.2) 173 (100) 191 (55.6) 517 (0.1) 163 (100) [10, 11]
∗The numbers of the peaks in this table coincide with the numbers of the peaks in Figure 5.
∗∗The deﬁnitions of B1, B2, B3, A1, and A2 were described in [11].4 Evidence-Based Complementary and Alternative Medicine
Table 4: HR-ESI-TOF-MSn data of ﬂavonoids and triterpenoid saponins identiﬁed in ACG.
peak no.∗ Rt min
CID spectra of [M-H]− (relative intensity, %)
Identiﬁcation Lit. report
[M-H]− Base ion Other ions
Flavonoids
4 20.3 609 (1.8) 301 (100) 463 (9.0), 271 (22.2) Quercetin 3-rutinoside [10]
5 22.4 463 (1.8) 301 (100) 285 (6.2), 271 (77.7) Quercetin 3-glucoside
6∗∗ 23.0 595 (4.6) 301 (100) 463 (24.7), 285 (8.4) Quercetin 3-vicianoside
7∗∗ 23.7 593 (4.3) 285 (100) 447 (23.8), 255 (37.6) Kaempferol 3-rutinoside [10]
Triterpenoid saponins
11 31.5 745 (1.1) 467 (100) 599 (48.3), 369 (14.6) 3-O-α-L-Rhamnopyranosyl-(1-2)-α-
L-arabinopy-ranosyl-α-kudinlactone [15]
12 32.0 1073 (0.1) 749 (100) 911 (19.8), 603 (7.9), 471 (3.6) Macranthoside B [16]
13 32.4 1073 (0.2) 749 (100) 911 (12.8), 603 (8.0), 471 (7.8) Isomer of 12 ∗∗∗
15 35.5 971 (0.1) 809 (100) 763 (49.9), 647 (6.5), 471 (8.9)
3-O-β-D-Glucopyranosyl-(1-4)-β-D-
Glucuronopyranosyl siaresinolic
acid-28-O-β-D-glucopyranosyl ester
[17]
16 37.0 955 (0.3) 793 (100) 631 (42.6), 455 (8.5) Isomer of 17 ∗∗∗
17 37.3 955 (0.8) 793 (100) 631 (38.6), 455 (10.2)
3-O-β-D-Glucopyranosyl-(1-4)-β-D-
glucuronopyranosyl oleanolic
acid-28-O-β-D-glucopyranosyl ester
[17]
Unknown compound
14 34.1 582 (0.6) 374 (100) Unknown
∗The numbers of the peaks in this table coincide with the numbers of the peaks in Figure 5.
∗∗Compounds 6 and 7 were not clearly separated in LC-MS analysis.
∗∗∗Since NMR data and the corresponding standards of these compounds were not available, identiﬁcation of these compounds could not be completed by
the LC-MS/MS in this study.
Extraction kit (Bioﬂux, Japan) according to the manufac-
turer’s instructions and suspended in diethylpyrocarbonate-
treated water. The concentration of the total RNA samples
was calculated from the optical density by an ultraviolet
spectrophotometersetatwavelengthsof260nmand280nm.
For preparation of cDNA, 2mg of each total RNA sample
was reverse-transcribed using RevertAid First Strand cDNA
Synthesis Kit (MBI Fermantas, Vilnius, Lithuania). The
resulting cDNA was used to amplify gene-speciﬁc cDNAs.
Quantitative real-time RT-PCR was performed on a BIO-
RADiCyclermachine(CA,USA).Ahousekeepingtranscript,
β-actin, was used as an internal control because of its stable
expression in vivo [18]. The primers used for each gene are
shown in Table 1. The PCR products were evaluated by their
meltingcurves(datanotshown).Theampliﬁedgene(4.8uL)
was resolved using agarose gel electrophoresis under 100V
and was stained with GelRed. Analysis of the PCR products
wascarriedoutwiththeLaunchVisionWorksLSandtheGel
Doc-ITImagingSystem.ThelevelofmRNAwasexpressedas
the ratio of signal intensity for each gene relative to that of β-
actin.
2.7. LC-DAD/HR-ESI-TOF-MS Analysis. The ACG was
thawed at room temperature, dissolved in 80% aqueous
methanol (10mg·mL−1 of methanol), and used directly
for LC-DAD/HR-ESI-TOF-MS analysis. LC-DAD separa-
tion was achieved on a 250 × 4.6mm i.d. Acclaim C18
column (Dionex, USA). Solvent A was water/formic acid
(1000:1v/v), and solvent B was acetonitrile/formic acid
(1000:1v/v). Solvents were delivered at a total ﬂow rate
of 0.5mL/min. The gradient proﬁle was from 15% B to
35% B linearly in 0–25min, 35% B to 100% B in 25–
45min and returned to 15% B at 50min. HR-ESI-TOF-MS
analyseswerecarriedoutusingaMicrOTOF-QIIFocusmass
spectrometer (Bruker Daltonics) ﬁtted with an ESI source
operating in Auto-MSn mode to obtain fragment ion m/z,
and internal calibration was achieved with 10mL of 0.1M
sodiumformatesolutionpriortoeachchromatographicrun.
MSoperatingconditionshadbeenoptimizedwithacapillary
of4500V(negativeionmode),acapillaryof5000V(positive
ion mode), an end plate oﬀset of −500 V, a collision cell RF
of 150Vpp, a dry heater temperature of 180◦C, a dry gas ﬂow
rate of 5.0L/min, and a nebulizer pressure of 3.0 bar. All MS
measurements were carried out in the positive and negative
ion modes, respectively.
2.8. Statistics. Data were analyzed using GraphPad Prism 5,
a computerized statistical analysis program software. The
signiﬁcance of diﬀerences between means was evaluated by
a t-test or one-way analysis of variance. Diﬀerences were
considered signiﬁcant at P<0.05. All data are shown as
means ± SD.
3. Results and Discussion
Most Traditional Chinese Medicine (TCM) remedies are
prepared in the form of decoctions and are administeredEvidence-Based Complementary and Alternative Medicine 5
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Figure 2: Serum glucose levels (a, b) and total cholesterol levels (c)
during treatment with ACG in type 2 diabetic mice.
orally. The eﬃcacy of TCM is a characteristic of a complex
mixture of chemical compounds which lead to complexity
of mechanisms of pharmacological activity. In our pre-
vious study, water extract of Ilex kudingcha was found
to possess an antidiabetic activity with a high does (15g
water extract·Kg−1·d−1 of Ilex kudingcha) on mice with
type 2 diabetes induced by alloxan. The water extract of
Ilex kudingcha contained polysaccharides, monosaccharides,
proteins, simple organic acids, and other natural products.
In addition, the antidiabetic eﬀects of three fractions (A, B,
and C) from water extract were examined, and the active
components present in Ilex kudingcha were low lipophilic
chemicals which could be dissolved in hot water or aqueous
methanol solvent. Fraction C did not show the antidiabetic
eﬀect. The chemicals in Fraction C, which did not dissolved
in 50% MeOH/H2O solvent, should be polysaccharides,
proteins,andotherpolarchemicalssuchasmonosaccharides
and simple organic acids. The purpose of this study was to
further clarify the anti-diabetic eﬀect of ACG using alloxan-
induced type 2 diabetic mice. Also, the phytochemicals in
ACG of Ilex kudingcha were systematically analyzed with a
DAD-HPLCcoupledwithonlinemassspectrometryusingan
ESI source.
3.1. General Parameters. Figure 1 shows the changes in
amount of eating food and drinking water during 4 weeks’
treatment with ACG. The food intake in KL, KM,a n dKH
groups was slightly lower than that in T group, but the
diﬀerences were not signiﬁcant except for the 16–28th days
of treatment (P<0.05) (Figure 1(a)). In the 24–28th days,
the eﬀect of KH group was even better than that of P group.
The water intake of KH group was signiﬁcantly lower than
that of T group (P<0.05) in 24–28th days (Figure 1(b)).
As shown in Table 2, the body weight of KH group was
signiﬁcantly lower than that in T groups (P<0.05) after 4
weeks. However, 4 weeks of ACG treatment failed to alter the
weight of the liver of type 2 diabetic mice, and there was no
diﬀerence in the weight of the same organ (heart, kidneys,
and pancreas) (data not shown).
Previous studies show alloxan injected to mice resulted
in loss of body weight, hyperphagia, and polidypsia. The loss
of body weight could be due to dehydration and catabolism
of fats and proteins [19]. In the present study, injection
of alloxan failed to alter the body weight of mice fed a
high-fat diet. And the body weight of mice treated with
phenformin have no signiﬁcant changes compared to that of
model mice, suggesting that phenformin may possesses weak
weight-losing eﬀectiveness in such a short time. Moreover,
treatment with ACG prevented the changes of water intake
and food consumption in type 2 diabetic mice. In addition,
alloxan-induced diabetes produced a signiﬁcant increase in
glucose levels associated with hyperphagia and polidypsia,
which have been decreased by ACG (Figure 1).
3.2. Eﬀect of Treatment on the Level of Blood Glucose and
OGTT. Alloxan-induced type 2 diabetic mice had signiﬁ-
cantly increased concentration of blood glucose compared
with mice in C group (P<0.05). There was a remarkable6 Evidence-Based Complementary and Alternative Medicine
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Figure 3: Gene expression analysis in the liver by real-time RT-PCR. (a) HMGCR; (b) FASN; (c) G6PC; (d) GCK. Signiﬁcant diﬀerences
were observed at P<0.05∗ versus T groups. β-actin was used as a control to standardize the eﬃciency of each reaction. Gene expression was
presented using a modiﬁcation of the 2−ΔΔCt method [12–14].Evidence-Based Complementary and Alternative Medicine 7
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Figure 5: LC-DAD chromatogram spectrum and HR-ESI-TOF-
MSn negative mass spectrum of ACG.
decrease in glucose levels of mice treated with ACG for 4
weeks compared to type 2 diabetic mice (P<0.05) (Table 2
and Figure 2(a)). Blood glucose levels increased signiﬁcantly
(P<0.05) after 0.5h of glucose loading in alloxan-treated
type 2 diabetic mice (Figure 2(b)). The blood glucose levels
in all groups were elevated after 2h and they did not recover
to the original levels. In addition, the elevation of blood
glucoselevelinKH groupwassigniﬁcantlysuppressedintype
2 diabetic mice at 0, 0.5, and 2h (P<0.05), but was still
higher than that of C group.
It is found that ACG signiﬁcantly suppressed the increase
in blood glucose levels (Figures 2(a) and 2(b)). Antihyper-
glycemiceﬀectofACGobservedinalloxan-inducedmicecan
be attributed to several mechanisms. Glucose homeostasis
depends largely on the balance between the formation of
sugar in the liver and its utilization in liver, muscle, and
adipose tissue. Therefore, energy metabolism in the other
organs such as adipose tissue and skeletal muscle might be
importantly related to the glucose metabolism of the ACG
groups, leading to the amelioration of glucose metabolism.
3.3. Serum Lipid Measurements. Table 2 and Figure 2(c)
show that cholesterol concentrations in serum were signif-
icantly increased in T group (P<0.05) when compared
with nondiabetic mice in C group. However, the alteration
in lipid metabolism was partially attenuated as evidenced by
decreased serum cholesterol levels after treatment with ACG.
Meanwhile, the serum triglyceride levels slightly decreased in
KL, KM,a n dKH groups. In addition, nonesteriﬁed fatty acid
levels were lower after 4 weeks in KL, KM,a n dKH groups
when compared with diabetic controls, but they did not
recover to normal level.
Diabetes is associated with profound alterations in the
plasma lipid and lipoprotein proﬁle as well an increased
risk of coronary heart disease [20]. In the present study,
the ability of ACG to partially reverse the hyperglycemia
of alloxan-treated mice was conﬁrmed. In addition to the
hypoglycemic activity of ACG, it also possessed a potent
lipid lowering properties in type 2 diabetic mice. The levels
of serum cholesterol, triglyceride, and nonesteriﬁed fatty
acid in alloxan-induced diabetes were higher than that of C
group. ACG treatment ameliorated these eﬀects, possibly by
controlling the hydrolysis of certain lipoproteins and their
selective uptake and metabolism by diﬀerent tissues.
3.4. Antioxidant Activity of ACG. The activities of superoxide
dismutase and malondialdehyde concentration in serum
of mouse are shown in Table 2. The activities of super-
oxide dismutase were suppressed in alloxan-induced type
2 diabetic mice. Furthermore, induction of diabetes by
alloxan caused a marked rise in serum malondialdehyde.
However, a signiﬁcant reactivation of antioxidant enzymes
was observed in KH group (P<0.05) after treatment with
3.81g ACG·Kg−1·d−1. The levels of serum malondialdehyde
were reversed in KL, KM,a n dKH groups as compared to
that of T group, but the changes were not signiﬁcant. In
addition, mice treatedwith phenformin showed an increased
superoxide dismutase level and decreased malondialdehyde
level compared to that of model mice. The eﬀectiveness was
reported previously [21].
There is an association between oxidative stress and
diabetes particularly through the generation of lipid perox-
idation. It is known that hyperglycemia can result in the
generation of reactive oxygen species and that it also inhibits
the activity of antioxidant enzymes by glycosylation [22].
Superoxide dismutase is a metalloenzyme which involved in
thedismutationofthesuperoxideaniontomolecularoxygen
and hydrogen peroxide [23]. It is reported that diabetics8 Evidence-Based Complementary and Alternative Medicine
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Figure 6: HR-ESI-TOF-MS/MS of three chlorogenic acids isomers identiﬁed in ACG and their structures. (a) Spectrum of Compound 1;
(b) spectrum of Compound 2; (c) spectrum of Compound 3.
usually exhibit high oxidative stress due to persistent and
chronichyperglycemia,whichthereby depletestheactivity of
antioxidative defense system and thus promotes free radicals
generation. And as byproduct of lipid peroxidation, mal-
ondialdehyde concentration reﬂects the degree of oxidation
in the diabetic mice [24]. In the present study, superoxide
dismutase and malondialdehyde were examined to ﬁnd out
the possible mechanism involved in the observed results.
The results show that ACG might aﬀect lipid proﬁle and
are responsible for their antidiabetic properties by slightly
reducingserummalondialdehydelevelandimprovingserum
superoxidedismutaseactivitytoattenuatethelipidperoxida-
tion caused by various forms of free radicals.
3.5. Quantitative Real-Time RT-PCR. To validate the bio-
chemical changes, four genes were examined by real-time
RT-PCR. The representative genes were selected according
to metabolic functions in terms of gluconeogenesis (G6pc),
glycolysis (Gck), lipid metabolism (Fasn), and cholesterol
synthesis (Hmgcr). As shown in Figure 3, the expressions of
Gck and Hmgcr in KH group were signiﬁcantly higher than
that in T group on RT-PCR evaluation. The expressions of
G6pc and Fasn in KH group was signiﬁcantly lower than that
in T group. Figure 4 shows that the results of real-time RT-
PCR correlated well (E = −98.7%, R2 = 0.975, slope = 0.527,
y-int=27.849),indicatingthatgeneexpressionproﬁlebyRT-
PCRwashighlyreliable,andhousekeepingtranscriptβ-actin
was suitable to standardize the eﬃciency of each reaction.
Gene expression of Hmgcr, a key enzyme in cholesterol
synthesis pathway, was upregulated signiﬁcantly inKH group
indicating that cholesterol synthesis is potently induced
by ACG treatment. In those diabetic mice, ingestion of
ACG increased the activity of Hmgcr which resulted in
the lowering of plasma cholesterol levels. These results may
be attributed to the increased excretion of bile acid and
cholesterol. The ACG treatment induced a deﬁciency in
hepatic cholesterol and its derivatives, leading to the potent
i n d u c t i o no fc h o l e s t e r o ls y n t h e s i sa n dc h o l e s t e r o lu p t a k ei n
the liver [25]. ACG ingestion upregulated the expression of
Gck gene and downregulated the expression of G6pc gene
related to glycometabolism (Figures 3(c) and 3(d)). Gck is
a member of the hexokinase family (hexokinase type IV)
that catalyzes the ﬁrst committed step in glycolysis. Either
upregulation of Gck gene expression or Gck enzyme activityEvidence-Based Complementary and Alternative Medicine 9
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Figure 7: HR-ESI-TOF-MS/MS of three dicaﬀeoylquinic acid isomers identiﬁed in ACG. (a) Spectrum of Compound 8;( b )s p e c t r u mo f
Compound 9; (c) spectrum of Compound 10.
h a sb e e nr e p o r t e dt ob ea b l et os u p p r e s sa ni n c r e a s ei nb l o o d
glucose [26]. These indicate that ACG ingestion activates
glycolysis. Another downregulated gluconeogenesis-related
gene, G6pc, is a key enzyme in gluconeogenesis, catalyzing
the hydrolysis of D-glucose 6-phosphate to D-glucose. Thus,
we concluded that ACG ingestion-induced suppression of
the increase in blood glucose levels was attributed mainly to
the activation of glycolysis and inactivation of gluconeogen-
esis in liver.
3.6. LC-DAD/HR-ESI-TOF-MS Analysis. In this study, six-
teen components including three chlorogenic acids isomers,
three dicaﬀeoylquinic acids isomers, four ﬂavonoids, and
six triterpenoid saponins were identiﬁed or characterized by
their MS/MS spectra and LC retention time.
Compounds 1(HR-ESI-MS: m/z 353.0953 [M-H]−), 2
(HR-ESI-MS: m/z 353.0950 [M-H]−), and 3 (HR-ESI-
MS: m/z 353.0957 [M-H]−) had the same [M-H]− ion
in accordance with a C16H17O9 formula of chlorogenic
acid (calculated for C16H18O9, 354.0951). Their product
ions at m/z 135 and 191 from collision-induced dissoci-
ation (CID) indicated that these three compounds were
chlorogenic acids isomers (Figure 6). The three chlorogenic
acids isomers neochlorogenic acid, chlorogenic acid, and
cryptochlorogenic acid have been identiﬁed in dried plums
and Ilex kudingcha by LC-MS/MS [10, 11]. By comparison of
the peak areas and retention time of these three chlorogenic
acids isomers on the C18 HPLC column, compounds 1,
2,a n d3 were identiﬁed here as neochlorogenic acid,
chlorogenic acid, and cryptochlorogenic acid, respectively.
Compounds 8, 9,a n d10 (HR-ESI-MS: [M-H]− at m/z
515.1269 for 8, 515.1270 for 9 and 515.1262 for 10) had the
same[M-H]− ion (Figure 7) in accordancewitha C25H23O12
formula of dicaﬀeoylquinic acid (calculated for C25H24O12,
516.1267), and their product ions at m/z 179, 135, 173, and
191 from CID, indicated that these compounds might be the
dicaﬀeoylquinic acids isomers. These compounds has been
reported in Ilexkudingchapreviously[10].Fourpairsofions:
[M-A1]− and A1;[ M - A2]− and A2; [M-B1]− and B1;a n d
[M-B2]− and B2 in MS/MS from negative ion mode of the
[M-H]− ions at m/z 353 (compounds 1, 2,a n d3) and 515 of
(compounds 8, 9,a n d10)( Table 3) suggested the diagnostic
fragmentation patterns of chlorogenic acid isomers and
dicaﬀeoylquinic acid isomers. The diagnostic fragmentation10 Evidence-Based Complementary and Alternative Medicine
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patterns involved cleavage of intact caﬀeoyl and quinic acid
fragments [11]. Using ESI-MS/MS in the positive ion mode,
the protonated molecular ions of chlorogenic acid isomers
and dicaﬀeoylquinic acid isomers gave only one ion at m/z
163. The typical fragmentation pathway resulted from the
positive ionization of the carbonyl oxygen [11]. In addition,
MS/MS of the [M-H]− ion at m/z 707 appeared on the side
of peak 2 and it was identiﬁed as a dimeric adduct ion of
chlorogenic in previous report [10].
HR-ESI-MS of compound 4 exhibited a deprotonated
molecular ion [M-H]−at m/z 609.1536 corresponding to
C27H29O16 (calculated for C27H30O16 [M-H]−, 610.1533),
and this compound was identiﬁed as rutin (quercetin 3-
rutinoside) based on product ions from CID of [M-H-146]−
at m/z 463 and [M-H-146–162]− at m/z 301, as reported
previously[10].BasedontheESIMS/MSdata,CIDpathways
of compounds 5 and 6 were similar to that of compounds
4, which suggest that these compounds possessed a same
aglycon quercetin with diﬀerent glycosides. Compound 5
had the [M-H]− ion at m/z 463 and product ion at m/z
301 [M-H-162]− from CID of [M-H]−, which suggested that
compound 5 was quercetin 3-glucoside. Compound 6 had
the [M-H]− at m/z 595 with its product ions [M-H-132-
162]− at m/z 301 and [M-H-132]− at m/z 463 suggested that
compound6wasquercetin3-vicianoside.Forthecompound
7, the [M-H]− at m/z 593 corresponding to C27H29O15,w i t h
its product ions [M-H-146–162]− at m/z 285 and [M-H-
146]− atm/z 447suggestedthatcompound7waskaempferol
3-rutinoside. This compound has been reported in Ilex
kudingcha [10].Evidence-Based Complementary and Alternative Medicine 11
Compound 11 had the [M-H]−ion at m/z 745.4247
(calculated for C41H62O12, 746.4241) was identiﬁed as
3-O-α-L rhamnopyranosyl-(1-2)-α-L-arabinopy-ranosyl-α-
kudinlactone based on product ions from CID of [M-146]−
and [M-H-146-132]− (Table 4 and Figure 8), as reported in
Ilex kudingcha previously [15]. HR-ESI-MS of compound 12
exhibited an [M-H]− ion at m/z 1073.5695 corresponding
to C53H85O22 (calculated for C53H86O22, 1074.5611), and
four ions at [M-H-162]−, [M-H-162-162]−, [M-H-162-
162-146]−, and [M-H-162-162-146-132]− indicated four
sugars in the structure. It showed similar CID fragmentation
with macranthoside B [16]. The MS/MS data from 13
were almost identical to those of 12 (Table 4), and it was
likely that 13 is a stereoisomer of 12 due to diﬀerent
conﬁguration of the triterpene ester. Compound 15 exhib-
ited an [M-H]− ion at m/z 971.4936 corresponding to
C48H75O20 (calculated for C48H76O20 [M-H]−, 972.4929).
Its MS/MS spectrum gave two ions of [M-H-162]− and
[M-H-162-162]−, strongly suggesting the presence of two
sugar moieties. HR-ESI-MS of compound 16 displayed the
[M-H]− ion at m/z 955.4991 corresponding to C48H75O19
(calculated for C48H76O19 [M-H]−, 956.4981). Like com-
pound 15, the loss of 162Da and 324Da originated from
the glucoside unit. Based on the high intensity signals,
compound 15 was identiﬁed as 3-O-β-D-glucopyranosyl-
(1-4)-β-D-glucuronopyranosyl siaresinolic acid-28-O-β-D-
glucopyranosyl ester and compound 17 was identiﬁed
as 3-O-β-D-glucopyranosyl-(1-4)-β-D-glucuronopyranosyl
oleanolic acid-28-O-β-D-glucopyranosyl ester. These two
compounds have been reported in Ilex godajam and Ilex
hylonoma [17]. In addition, compound 16 was characterized
asisomersofcompound17duetothesame[M-H]− ionsand
fragmentation patterns. The compounds 5, 6, 12, 13, 15, 16,
and 17 were newly found in Ilex Kudingcha. Since NMR data
and the corresponding standards of the compounds 13 and
16 were not available, identiﬁcations of these compounds
could not be completed by the LC-MS/MS in this study.
Theﬂavonoidshavelongbeenrecognizedtopossessanti-
inﬂammatory, antioxidant, antiallergic, antiatherosclerotic
and antidiabetic eﬀects [27]. Previous study showed that
rutin possessed partial protective eﬀect on multiple low-dose
streptozotocin-induceddiabetesinmice[28].However,rutin
and its similar compounds orally administered to diabetic
mice should not decrease elevated blood glucose level in
short-time (4 weeks) [29]. In addition, dicaﬀeoylquinic acids
have attracted attention because of its potentiating eﬀect on
bile secretion and, therefore, its moderating eﬀect on blood
cholesterol levels [11]. Also, dicaﬀeoylquinic acids have been
studiedasapotentiallyimportantclassofHIVinhibitorsthat
act at a site distinct from that of current HIV therapeutic
agents [30]. It also has been reported that Ilex kudingcha
total saponins could improve total cholesterol, triglyceride
in ApoE−/− mice [31]. While ﬂavonoids and chlorogenic
acids have a strong UV absorption, small UV peaks of 1–
7 indicated that ﬂavonoids (4–7) are trace components and
chlorogenicacids(1,2,and3)areminorcomponentsinACG
(Figure 5). Therefore, the major principles in ACG are three
dicaﬀeoylquinic acids (8, 9,a n d10) and three triterpenoid
saponins (12, 13,a n d15).
4. Conclusions
ACG treatment signiﬁcantly reduced the elevated levels of
serum glycaemic and lipids in type 2 diabetic mice and
improvedtheirlevelsofgenesthoserelatedtotype2diabetes.
It is reasonable to assume that antidiabetic activity of Ilex
kudingcha against hyperglycemia is resulted from the major
principles including three dicaﬀeoylquinic acids and three
triterpenoid saponins. Also, it is possible that synergistic
eﬀects among their compounds exist in the antidiabetic
activity of Ilex kudingcha.
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